Lymphangioleiomyomatosis - 19 Studies Found

Completed : National Lymphangioleiomyomatosis Registry, France
: Lymphangioleiomyomatosis
: 2011-11-30
Completed : Efficacy and Safety of Sirolimus for Treating Lymphangioleiomyomatosis (LAM)
: Lymphangioleiomyomatosis
: 2006-12-20
:
  • Drug: Sirolimus A sirolimus do
Completed : Pulmonary Rehabilitation in Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2013-12-04
: Other: Pulmonary Rehabilitation
Completed : The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
: Pulmonary Lymphangioleiomyomatosis
: 2014-04-15
: Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont
Completed : Trial of Aromatase Inhibition in Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2011-05-11
:
  • Drug: Letrozole 2.5 mg daily f
Completed : A Study to Determine the Effectiveness of Escalating Doses of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2010-01-28
: Drug: Everolimus
Completed : A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
: Lymphangioleiomyomatosis
: 2016-10-07
: Drug: Nintedanib Other Name: OFEV
Completed : Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2013-02-23
:
  • Drug: albuterol inhaler
  • Procedure: PFT
Completed : Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
: Pulmonary Lymphangioleiomyomatosis
: 2016-03-31
: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi
Completed : Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
: Lymphangioleiomyomatosis
: 2012-08-02
: Drug: sirolimus and hydroxychloroquine This will be a phase I dose escalation study of the combination o
Next >>>